SCHEMBL30890648

SCHEMBL30890648

CCCCOC[C@H](NC)C(=O)N1C[C@@]2(C[C@H]1C(N)=O)Oc1cc(F)cc(F)c1NC2=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890580 1.00 — —
Hydrochloric Acid SCHEMBL30890683 0.85 — —
SCHEMBL30890477 0.82 — —
SCHEMBL30890592 0.81 ITGB3 (0.34) —
SCHEMBL30890688 0.80 — —
SCHEMBL30890722 0.76 MEN1 (0.33) —
SCHEMBL30890800 0.75 IMPDH2 (0.30) —
SCHEMBL30890776 0.74 MEN1 (0.31) —
SCHEMBL30890449 0.73 — —
SCHEMBL30992245 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback